ART352-L

N/A

Report date: 2024/11/27 10:27:04

Base Information

Drug NameART352-L
Drug Alias NameART352-L
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProtein Wnt-3a replacement
TargetsProtein Wnt-3a
Therapy Area/IndicationsSpondylolisthesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAnkasa Regenerative Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnkasa Regenerative Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSpondylolisthesis

Other Information

ATC CodeN/A
Related LinksN/A